Scienture Holdings (SCNX) Gross Margin (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Gross Margin came in at 97.71% in Q2 2026, up 2.2% quarter-over-quarter from 95.61% in Q1 2026.
Analysis
Scienture Holdings (SCNX) Gross Margin (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Gross Margin across 14 years of filings, most recently posting 97.71% for Q2 2026.
- In Q2 2026, Gross Margin changed N/A year-over-year to 97.71%; the TTM figure through Jun 2026 stood at 95.14% (down 1084.0% YoY), while the FY2025 annual figure was 76.8%, up 7241.0% from the prior year.
- Gross Margin came in at 97.71% for Q2 2026 at Scienture Holdings, up from 95.61% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 105.31% in Q4 2023 to a low of 3.76% in Q2 2024.
- Average Gross Margin over 5 years is 50.25%, with a median of 41.58% recorded in 2022.
- Year-over-year, Gross Margin tumbled 2638 bps in 2023 and surged 8905 bps in 2026.
- Over 5 years, Gross Margin stood at 41.94% in 2022, then jumped by 151 bps to 105.31% in 2023, then tumbled by 104 bps to 3.76% in 2024, then surged by 275 bps to 6.56% in 2025, then jumped by 1389 bps to 97.71% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 97.71% in Q2 2026, 95.61% in Q1 2026, and 6.56% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 51.98% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 38.77% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 46.52% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 42.01% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 73.60% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 62.35% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 4.68% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 50.83% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 95.97% |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 97.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.71% |
| Mar 31, 2026 | 95.61% |
| Mar 31, 2025 | 6.56% |
| Jun 30, 2024 | -3.76% |
| Dec 31, 2023 | 105.31% |
| Sep 30, 2023 | 82.83% |
| Jun 30, 2023 | 18.32% |
| Mar 31, 2023 | 14.84% |
| Dec 31, 2022 | 41.94% |
| Sep 30, 2022 | 66.76% |
| Jun 30, 2022 | 35.71% |
| Mar 31, 2022 | 41.22% |
| Dec 31, 2021 | 51.94% |
| Sep 30, 2021 | 50.24% |
| Jun 30, 2021 | 44.32% |
| Mar 31, 2021 | 45.31% |
| Dec 31, 2020 | 6.67% |
| Sep 30, 2020 | 30.47% |
| Jun 30, 2020 | 30.41% |
| Mar 31, 2020 | 74.44% |